ONTX

Onconova Therapeutics Inc.

Price

$9.82

return (12m)

p/e

-9.81

p/bv

13.64

DIVIDEND YIELD

0.00%

ONTX price

Onconova Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*The amount considers the reinvestment of dividends.

Return on Investment ONTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-32.92%

3 months

-51.58%

1 year

0.00%

2 years

0.00%

5 years

165.41%

10 years

-98.31%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals ONTX

Valuation

P/E

-9.81

Sector 0.84

Industry -1.42

P/BV

13.64

Sector 1.82

Industry 1.25

P/Revenue (PSR)

876.22

Sector 1.48

Industry 2.13

EV/EBITDA

Sector -43.66

Industry -35.45

EV/EBIT

Sector -47.57

Industry -38.86

P/EBITDA

-17.64

Sector -31.25

Industry -21.12

P/EBIT

-17.63

Sector -42.58

Industry -25.59

P/Total Assets

7.32

Sector 0.82

Industry 0.70

P/Net Current Assets

Sector -23.77

Industry -59.56

P/Working Capital

Sector -3.73

Industry -1.93

EPS

-0.96

Sector -0.70

Industry -1.22

BVPS

0.69

Sector 4.50

Industry 2.78

Efficiency

Gross Margin

75.22%

Sector 49.32%

Industry 49.70%

EBITDA Margin

-8,928.07%

Sector -305.63%

Industry -17,123,193.33%

EBIT Margin

-100.00%

Sector -19.73%

Industry -25.36%

Net Profit Margins

-100.00%

Sector -23.90%

Industry -27.40%

Asset Turnover

0.00

Sector 0.13

Industry 0.06

Profitability

ROE

-139.04%

Sector -24.30%

Industry -38.97%

ROA

-74.65%

Sector -24.50%

Industry -49.14%

ROIC

Sector -584.46%

Industry -1,072.15%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

Sector 1.92

Industry 2.55

Net Debt / EBITDA

Sector -23.10

Industry -8.80

Net Debt / EBIT

Sector -17.84

Industry -36.75

Net Debt / Equity

Sector -0.68

Industry -1.16

Gross Debt / Equity

Sector -0.72

Industry -0.54

Equity/Assets

0.54

Sector 0.46

Industry 0.52

Liabilities/Assets

0.46

Sector 0.50

Industry 0.47

Growth

5Y Revenue CAGR

0.09%

Sector -

Industry -

5Y Earnings CAGR

4.54%

Sector -

Industry -

Fundamentals ONTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price ($)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ONTX Onconova Therapeutics Inc.	$9.82	-	0.00%	-9.81	13.64	-139.04%	-100.00%
LLY Eli Lilly and Compay	$1,249.76	56.65%	0.53%	42.13	33.21	78.84%	33.53%
SNY Sanofi	$39.81	-18.25%	4.38%	3.78	0.70	18.43%	14.25%
GSK GlaxoSmithKline PLC	$49.36	16.30%	3.58%	15.38	4.34	28.24%	14.54%
CRMD CorMedix Inc.	$7.48	-26.52%	0.00%	3.04	1.23	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$25.97	9.21%	0.00%	14.41	1.47	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$13.05	-9.04%	0.64%	29.37	2.65	9.03%	10.14%
JNJ Johnson & Johnson	$252.71	34.46%	2.08%	29.04	7.19	24.76%	21.48%
ISRG Intuitive Surgical Inc.	$431.59	-3.26%	0.00%	48.53	8.32	17.15%	28.44%
NVS Novartis AG	$150.19	16.49%	2.05%	22.56	6.86	30.41%	23.29%
TMO Thermo Fisher Scientific Inc.	$673.79	25.46%	0.27%	36.53	4.83	13.22%	15.04%
ABT Abbott Laboratories	$103.75	-16.91%	2.53%	31.55	3.35	10.61%	11.65%
MDT Medtronic PLC	$92.84	0.14%	3.02%	23.20	2.39	10.29%	13.93%
CVS CVS Health Corporation	$91.15	14.82%	2.89%	24.09	1.47	6.12%	1.18%
BSX Boston Scientific Corp.	$44.56	-55.10%	0.00%	17.83	2.63	14.73%	17.49%
TMDX TransMedics Group Inc.	$72.35	-38.50%	0.00%	16.36	4.79	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$556.87	-12.36%	0.00%	38.87	27.47	70.67%	25.03%
RMD ResMed Inc.	$239.43	-9.75%	1.03%	22.76	5.27	23.13%	26.94%
DHR Danaher Corporation	$224.14	8.20%	0.63%	40.42	3.08	7.61%	15.95%
HCA HCA Healthcare Inc.	$454.64	7.19%	0.66%	14.90	-31.76	-213.15%	8.77%
COHR Coherent Inc.	$240.39	106.61%	0.00%	57.23	4.10	7.16%	11.31%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ONTX - Historical Dividends

no dividend paid in the period.

Current Dividend Yield

0.00%

5-year average Dividend Yield

0.00%

Current Payout

—

5-year average Payout

—

ABOUT Onconova Therapeutics

Onconova Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

28 years

Founded: 1998

2013

Time since IPO - 13 years

12

Employees

Onconova Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $198.03 million, with shareholders equity totaling $14.52 million.

The company employs approximately 12 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Onconova Therapeutics Inc. reported $226.00 Thousand in revenue, generating net income of $-20.18 million.

Key financial metrics include a P/E ratio of -9.81, a price-to-book (P/B) ratio of 13.64, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ONTX.

Market cap

$198.03 million

Net worth

$14.52 million

$14,517,000.00

Assets

$27.04 million

$27,038,000.00

Total Shares Outstanding

21.00 million

21,002,000

Average Daily Trading Volume

$6.00 Thousand

$5,995.76

Sector

Health

Industry

Pharmaceutical Products

ONTX

ONTX revenue and profits

Financial Results ONTX

DRAG THE FRAME TO SEE MORE DATA

ONTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$91.15 14,82% (12M)

P/E

24.09

2.89%

ROE

6.12%

P/BV

1.47

CI - Cigna

$296.71 1,38% (12M)

P/E

11.63

2.05%

ROE

16.04%

P/BV

1.87

CNC - Centene

$68.16 93,24% (12M)

P/E

-6.73

0.00%

ROE

-22.53%

P/BV

1.52

HUM - Humana

$411.55 52,12% (12M)

P/E

39.10

0.85%

ROE

6.63%

P/BV

2.59

SNY - Sanofi

$39.81 --18,25% (12M)

P/E

3.78

4.38%

ROE

18.43%

P/BV

0.70

JNJ - Johnson & Johnson

$252.71 34,46% (12M)

P/E

29.04

2.08%

ROE

24.76%

P/BV

7.19

LLY - Eli Lilly

$1,249.76 56,65% (12M)

P/E

42.13

0.53%

ROE

78.84%

P/BV

33.21

HCA - HCA Healthcare

$454.64 7,19% (12M)

P/E

14.90

0.66%

ROE

-213.15%

P/BV

-31.76